Inventor
ZHOU HAN-JIE
US41 patents
⚠️ This page may combine multiple inventors who share the name “ZHOU HAN-JIE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ONYX THERAPEUTICS INC
11 patentsUS7691852B2Apr 6, 2010
Compounds for enzyme inhibition
ONYX THERAPEUTICS INC65 citations99
US8431571B2Apr 30, 2013
Compounds for enzyme inhibition
ONYX THERAPEUTICS INC33 citations96
US8357683B2Jan 22, 2013
Compounds for enzyme inhibition
ONYX THERAPEUTICS INC34 citations96
US8609654B1Dec 17, 2013
Compounds for enzyme inhibition
ONYX THERAPEUTICS INC8 citations84
US9205124B2Dec 8, 2015
Compounds for enzyme inhibition
ONYX THERAPEUTICS INC8 citations83
US9205125B2Dec 8, 2015
Compounds for enzyme inhibition
ONYX THERAPEUTICS INC8 citations83
US9205126B2Dec 8, 2015
Compounds for enzyme inhibition
ONYX THERAPEUTICS INC8 citations83
US8765745B2Jul 1, 2014
Compounds for enzyme inhibition
ONYX THERAPEUTICS INC1 citations63
US9657058B2May 23, 2017
Compounds for enzyme inhibition
ONYX THERAPEUTICS INC0 citations52
US8735441B2May 27, 2014
Compounds for enzyme inhibition
ONYX THERAPEUTICS INC0 citations52
US10150794B2Dec 11, 2018
Compounds for enzyme inhibition
ONYX THERAPEUTICS INC0 citations51
ESSA PHARMA INC
7 patentsUS11518747B2Dec 6, 2022
Solid forms of an N-terminal domain androgen receptor inhibitor and uses thereof
ESSA PHARMA INC6 citations84
US11358938B2Jun 14, 2022
Solid forms of an N-terminal domain androgen receptor inhibitor and uses thereof
ESSA PHARMA INC8 citations84
US11242324B2Feb 8, 2022
Solid forms of an n-terminal domain androgen receptor inhibitor and uses thereof
ESSA PHARMA INC9 citations84
US11059795B2Jul 13, 2021
Androgen receptor modulators and methods for their use
ESSA PHARMA INC12 citations83
US11485713B2Nov 1, 2022
Androgen receptor modulators and methods for their use
ESSA PHARMA INC10 citations82
US11814357B2Nov 14, 2023
Solid forms of an N-terminal domain androgen receptor inhibitor and uses thereof
ESSA PHARMA INC1 citations71
US12109179B2Oct 8, 2024
Pharmaceutical compositions and combinations comprising inhibitors of the androgen receptor and uses thereof
ESSA PHARMA INC0 citations59
CLEAVE BIOSCIENCES INC
6 patentsUS9062026B2Jun 23, 2015
Fused pyrimidines and substituted quinazolines as inhibitors of p97
CLEAVE BIOSCIENCES INC6 citations82
US9828363B2Nov 28, 2017
Fused pyrimidines as inhibitors of P97 complex
CLEAVE BIOSCIENCES INC3 citations71
US10010554B2Jul 3, 2018
Fused pyrimidines as inhibitors of P97 complex
CLEAVE BIOSCIENCES INC1 citations61
US9475824B2Oct 25, 2016
Fused pyrimidines as inhibitors of p97 complex
CLEAVE BIOSCIENCES INC1 citations61
US10174005B2Jan 8, 2019
Fused pyrimidines as inhibitors of p97 complex
CLEAVE BIOSCIENCES INC0 citations50
US9868722B2Jan 16, 2018
Monocyclic pyrimidine/pyridine compounds as inhibitors of P97 complex
CLEAVE BIOSCIENCES INC1 citations50
BAYER AG
4 patentsUS10815215B2Oct 27, 2020
2,4,5-trisubstituted 1,2,4-triazolones useful as inhibitors of DHODH
BAYER AG5 citations82
US10968216B2Apr 6, 2021
4,5-annulated 1,2,4-triazolones
BAYER AG3 citations70
US12486248B2Dec 2, 2025
2,4,5-trisubstituted 1,2,4-triazolones useful as inhibitors of DHODH
BAYER AG0 citations60
US11787797B2Oct 17, 2023
4,5-annulated 1,2,4-triazolones
BAYER AG0 citations59